Solarvest Bioenergy Inc

Healthcare CA SVS

NoneCAD
0.00(0%)

Last update at 2024-02-15T20:03:42.180983Z

Day Range

LowHigh

52 Week Range

0.010.11

LowHigh

Fundamentals

Previous Close 0.03
Market Cap1.52M
VolumeNone
P/E Ratio-
Dividend Yield-%
EBITDA-1.95596M
Revenue TTM0.00074M
Revenue Per Share TTM-
Gross Profit TTM -0.01061M
Diluted EPS TTM-0.04

Overview
Financials
Peer Comparison
Reports
Stock Research & News
Profile

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown	2023-07-31	2022-07-31	2021-07-31	2020-07-31	2019-07-31
Type	yearly	yearly	yearly	yearly	yearly
Date	2023-07-31	2022-07-31	2021-07-31	2020-07-31	2019-07-31
Income before tax	-2.41499M	-1.62788M	-3.46000M	-1.54141M	-1.39276M
Minority interest	-	-	-	-	-
Net income	-2.41499M	-1.62788M	-3.46000M	-1.54141M	-1.39276M
Selling general administrative	1.08M	0.46M	1.27M	0.52M	0.49M
Selling and marketing expenses	-	-	-	-	-
Gross profit	0.00053M	-0.00038M	0.00026M	-	-0.00583M
Reconciled depreciation	0.06M	0.09M	0.09M	0.11M	0.10M
Ebit	-	-1.51862M	-2.32885M	-1.46838M	-1.26981M
Ebitda	-	-1.44850M	-3.25796M	-1.36944M	-1.25200M
Depreciation and amortization	-	-	-	-	-
Non operating income net other	-	-	-	-	-
Operating income	-2.21734M	-1.54154M	-2.37839M	-1.47554M	-1.31755M
Other operating expenses	-	-	-	-	-
Interest expense	0.12M	0.09M	0.11M	0.00000M	0.04M
Tax provision	-	-	-	-	-
Interest income	-	-	-	-	-
Net interest income	-0.12338M	-0.09193M	-0.10851M	-0.10626M	-0.08047M
Extraordinary items	-	-	-	-	-
Non recurring	-	-	-	-	-
Other items	-	-	-	-	-
Income tax expense	-	-	-	-	-
Total revenue	0.00098M	0.00103M	0.00215M	0.00972M	0.00000M
Total operating expenses	2.22M	1.54M	2.38M	1.49M	1.32M
Cost of revenue	0.00045M	0.00140M	0.00189M	-	0.00583M
Total other income expense net	-0.07426M	0.00559M	-0.97310M	0.04M	0.00526M
Discontinued operations	-	-	-	-	-
Net income from continuing ops	-2.41499M	-1.62788M	-3.46000M	-1.54141M	-1.39276M
Net income applicable to common shares	-	-1.62788M	-3.46000M	-1.54141M	-1.39276M
Preferred stock and other adjustments	-	-	-	-	-

Breakdown	2023-07-31	2022-07-31	2021-07-31	2020-07-31	2019-07-31
Type	yearly	yearly	yearly	yearly	yearly
Date	2023-07-31	2022-07-31	2021-07-31	2020-07-31	2019-07-31
Total assets	0.63M	1.19M	2.30M	3.07M	3.62M
Intangible assets	0.16M	0.18M	0.21M	0.23M	0.25M
Earning assets	-	-	-	-	-
Other current assets	-	-	-	0.96M	1.80M
Total liab	6.25M	5.22M	4.70M	5.45M	4.83M
Total stockholder equity	-5.61524M	-4.03099M	-2.40311M	-2.37905M	-1.20277M
Deferred long term liab	-	-	-	-	-
Other current liab	-	0.10M	0.02M	0.01M	1.10M
Common stock	-	9.93M	9.93M	7.40M	7.00M
Capital stock	10.26M	9.93M	9.93M	7.40M	7.00M
Retained earnings	-18.95564M	-16.54065M	-14.91277M	-11.45277M	-9.87674M
Other liab	-	-	0.79M	-	-
Good will	-	-	-	-	-
Other assets	-	-	-	-	-
Cash	0.02M	0.02M	1.39M	0.55M	0.06M
Cash and equivalents	-	-	-	-	-
Total current liabilities	5.70M	1.25M	0.94M	2.36M	2.15M
Current deferred revenue	-	-	-	-	-
Net debt	2.76M	2.89M	1.45M	2.41M	2.85M
Short term debt	-	-	-	-	0.23M
Short long term debt	2.76M	0.21M	0.16M	0.20M	0.23M
Short long term debt total	-	-	-	-	-
Other stockholder equity	-	-	0.88M	1.04M	1.16M
Property plant equipment	-	0.54M	0.57M	0.70M	0.40M
Total current assets	0.03M	0.47M	1.53M	2.13M	2.97M
Long term investments	-	-	-	-	-
Net tangible assets	-	-4.21172M	-2.60829M	-2.60868M	-1.45685M
Short term investments	-	-	0.00000M	0.60M	1.10M
Net receivables	0.01000M	0.01M	0.02M	0.98M	1.81M
Long term debt	0.03M	2.69M	2.68M	2.76M	2.68M
Inventory	0.00000M	0.41M	0.10M	-	-
Accounts payable	0.72M	0.70M	0.52M	1.17M	0.81M
Total permanent equity	-	-	-	-	-
Noncontrolling interest in consolidated entity	-	-	-	-	-
Temporary equity redeemable noncontrolling interests	-	-	-	-	-
Accumulated other comprehensive income	-	-	-	-	-
Additional paid in capital	-	-	-	-	-
Common stock total equity	-	-	-	-	-
Preferred stock total equity	-	-	-	-	-
Retained earnings total equity	-	-	-	-	-
Treasury stock	-	-	-	-	-
Accumulated amortization	-	-	-	-	-
Non currrent assets other	-	-	-	-	0.65M
Deferred long term asset charges	-	-	-	-	-
Non current assets total	0.60M	0.72M	0.77M	0.93M	0.65M
Capital lease obligations	0.00000M	0.29M	0.33M	0.37M	-
Long term debt total	-	-	-	-	-

Breakdown	2023-07-31	2022-07-31	2021-07-31	2020-07-31	2019-07-31
Type	yearly	yearly	yearly	yearly	yearly
Date	2023-07-31	2022-07-31	2021-07-31	2020-07-31	2019-07-31
Investments	-0.28550M	-0.03436M	0.26M	1.42M	0.10M
Change to liabilities	-	0.26M	-0.46352M	0.44M	-0.01788M
Total cashflows from investing activities	-	-0.03436M	0.64M	1.40M	0.10M
Net borrowings	-	0.18M	-0.16730M	0.11M	0.00765M
Total cash from financing activities	1.42M	0.18M	2.66M	0.11M	1.07M
Change to operating activities	-	-0.01468M	-0.01160M	-0.00211M	-0.00041M
Net income	-2.41499M	-1.62788M	-3.46000M	-1.54141M	-1.39276M
Change in cash	0.00401M	-1.37235M	0.84M	0.49M	-0.07075M
Begin period cash flow	0.02M	1.39M	0.55M	0.06M	0.13M
End period cash flow	0.02M	0.02M	1.39M	0.55M	0.06M
Total cash from operating activities	-1.13362M	-1.52154M	-2.46083M	-1.02031M	-1.24206M
Issuance of capital stock	0.54M	0.00000M	2.88M	-	1.18M
Depreciation	0.06M	0.09M	0.09M	0.11M	0.10M
Other cashflows from investing activities	-	-	-	-	-
Dividends paid	-	-	-	-	-
Change to inventory	-0.04784M	-0.30664M	-0.10336M	-0.10336M	-0.10336M
Change to account receivables	0.00318M	0.00660M	0.00051M	-0.00549M	0.00454M
Sale purchase of stock	-	-	-	-	-
Other cashflows from financing activities	-	-	-0.04920M	-0.04920M	-0.11052M
Change to netincome	-	0.07M	1.48M	-0.02107M	0.06M
Capital expenditures	0.31M	0.03M	0.02M	0.02M	0.00557M
Change receivables	-	-	-	-	-
Cash flows other operating	-	-	-	-	-
Exchange rate changes	-	-	-	-	-
Cash and cash equivalents changes	-	-	-	-	-
Change in working capital	0.23M	-0.05311M	-0.57797M	0.44M	-0.01375M
Stock based compensation	0.34M	0.00000M	0.44M	-	-
Other non cash items	0.12M	0.07M	0.06M	0.03M	0.06M
Free cash flow	-1.43938M	-1.55590M	-2.48348M	-1.03764M	-1.24763M

Peer Comparison

Sector: Healthcare Industry: Biotechnology

Company	Change (CAD)	Price (CAD)	Trailing PE (x)	Forward PE (x)	Price Sales TTM (x)	Price to Book Value (x)	Enterprise Value to Revenue (x)	Enterprise Value to EBITDA (x)
SVS Solarvest Bioenergy Inc	- -%	-	-	-	2052.55	24.50	5788.30	-2.0734
SHRX Sharp Therapeutics Corp.	- -%	1.00	-	-	-	32.37
NRX NurExone Biologic Inc.	-0.01 1.79%	0.55	-	6.90	-	15.26	-7.2365
MIR MedMira Inc	- -%	0.07	-	-	223.37	-	293.42	-80.0318
TTI Thiogenesis Therapeutics Corp.	- -%	0.56	-	-	-	15.17	-58.1577

Reports Covered

View All

Profile

Solarvest BioEnergy Inc. engages in the development of algal-based production systems to produce natural based green commercial products. It provides human nutrition products, including omega-3; clean energy production system that enables for continuous hydrogen production; and active ingredients for human health comprising cannabinoids in algae and bone morphogenetic protein for the treatment of repairing bone fractures. Solarvest BioEnergy Inc. has a collaborative research and development agreement with FSD Pharma Inc. to produce cannabidiol (CBD), Cannabigerol (CBG), and tetrahydrocannabinol (THC) programs. The company was incorporated in 2005 and is based in Vancouver, Canada.

Solarvest Bioenergy Inc

439 Helmcken Street, Vancouver, BC, Canada, V6B 2E6

674 204 4095
https://www.solarvest.ca

Key Executives

Name	Title	Year Born
Mr. Gerri J. Greenham	Pres	1951
Mr. Gerard Watts	Interim Chief Financial Officer	NA
Mr. Garth Greenham	Chief Operating Officer	NA
Mr. Claes Ellegaard	CEO & Additional Director	NA
Mr. Richard T. Groome BA	Chairman of Financial Advisory Committee	1959

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.